In one such design, a hydrophobic PS (ICG-ODA) was embedded in the liposomal membrane, doxorubicin (DOX) was encapsulated in the aqueous core, and the surface was functionalized with anti-HER2 antibodies for tumor-specific targeting (Figure 3E) [100,102]. Here, ERBB2 is linked to neoplasm.